Page last updated: 2024-09-03

imatinib mesylate and Lymphoma, Large-Cell, Anaplastic

imatinib mesylate has been researched along with Lymphoma, Large-Cell, Anaplastic in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Laimer-Gruber, D	1
Amenitsch, L; Artaker, M; Cheng, M; Dolznig, H; Eferl, R; Egger, G; Hassler, MR; Heider, S; Höfler, G; Inghirami, G; Jaeger, U; Kenner, L; Knapp, S; Kollmann, K; Lagger, S; Laimer, D; Landra, I; Medico, E; Merkel, O; Messana, K; Moriggl, R; Penninger, JM; Piccaluga, PP; Pileri, S; Piva, R; Ruggeri, BA; Schiefer, AI; Schlederer, M; Sexl, V; Shehata, M; Simonitsch-Klupp, I; Staber, PB; Thallinger, C; Todaro, M; Turner, SD; Valent, P; Vesely, PW; Weichhart, T	1
Georgakis, GV; Medeiros, LJ; Oyarzo, M; Rassidakis, GZ; Younes, A	1

Reviews

1 review(s) available for imatinib mesylate and Lymphoma, Large-Cell, Anaplastic

Article	Year
[Blockade of the PDGF receptor: a new and effective therapy option for NPM-ALK-dependent lymphoma]. Der Pathologe, 2014, Volume: 35 Suppl 2 Topics: Adolescent; Adult; Animals; Benzamides; Child; Humans; Imatinib Mesylate; Lymph Nodes; Lymphoma, Large-Cell, Anaplastic; Mice; Multimodal Imaging; Piperazines; Positron-Emission Tomography; Protein-Tyrosine Kinases; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Tomography, X-Ray Computed; Young Adult	2014

Article

Year

[Blockade of the PDGF receptor: a new and effective therapy option for NPM-ALK-dependent lymphoma].

Der Pathologe, 2014, Volume: 35 Suppl 2

Topics: Adolescent; Adult; Animals; Benzamides; Child; Humans; Imatinib Mesylate; Lymph Nodes; Lymphoma, Large-Cell, Anaplastic; Mice; Multimodal Imaging; Piperazines; Positron-Emission Tomography; Protein-Tyrosine Kinases; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Tomography, X-Ray Computed; Young Adult

2014

Other Studies

2 other study(ies) available for imatinib mesylate and Lymphoma, Large-Cell, Anaplastic

Article	Year
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. Nature medicine, 2012, Volume: 18, Issue:11 Topics: Adult; Anaplastic Lymphoma Kinase; Animals; Benzamides; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Lymphoma, Large-Cell, Anaplastic; Mice; Mice, Transgenic; Molecular Targeted Therapy; Neoplasm Staging; Nuclear Proteins; Nucleophosmin; Oncogene Protein p65(gag-jun); Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Receptor Protein-Tyrosine Kinases; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Remission Induction; Stem Cell Transplantation; Transcription Factor AP-1; Translocation, Genetic	2012
Lack of c-kit (CD117) expression in CD30+ lymphomas and lymphomatoid papulosis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2004, Volume: 17, Issue:8 Topics: Antineoplastic Agents; Benzamides; Cell Division; Cell Line, Tumor; Flow Cytometry; Hodgkin Disease; Humans; Imatinib Mesylate; Immunohistochemistry; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Lymphomatoid Papulosis; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm	2004

Article

Year

PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas.

Nature medicine, 2012, Volume: 18, Issue:11

Topics: Adult; Anaplastic Lymphoma Kinase; Animals; Benzamides; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Lymphoma, Large-Cell, Anaplastic; Mice; Mice, Transgenic; Molecular Targeted Therapy; Neoplasm Staging; Nuclear Proteins; Nucleophosmin; Oncogene Protein p65(gag-jun); Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Receptor Protein-Tyrosine Kinases; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Remission Induction; Stem Cell Transplantation; Transcription Factor AP-1; Translocation, Genetic

2012

Lack of c-kit (CD117) expression in CD30+ lymphomas and lymphomatoid papulosis.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2004, Volume: 17, Issue:8

Topics: Antineoplastic Agents; Benzamides; Cell Division; Cell Line, Tumor; Flow Cytometry; Hodgkin Disease; Humans; Imatinib Mesylate; Immunohistochemistry; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Lymphomatoid Papulosis; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm

2004